UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 28, 2017 (December 22, 2017)

 

Blue Sphere Corporation

(Exact name of registrant as specified in its charter)

 

Nevada   000-55127   98-0550257
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

301 McCullough Drive, 4th Floor, Charlotte, North Carolina 28262
(Address of principal executive offices) (Zip Code)

 

704-909-2806

(Registrant’s telephone number, including area code)

 

 

(Former Name or Former Address, if Changed since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

☒  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

  

As used in this Current Report, all references to the terms “we”, “us”, “our”, “Blue Sphere” or the “Company” refer to Blue Sphere Corporation and its wholly-owned subsidiaries, unless the context clearly requires otherwise.

 

Explanatory Note

 

This Current Report on Form 8-K/A is being filed to amend the Current Report on Form 8-K filed by the Company on December 28, 2015 and the Current Report on Form 8-K filed by the Company on March 24, 2017.

 

Unless otherwise indicated in this Current Report, all the Company’s common stock, par value $0.001 per share (“Common Stock”), share and per share information, including price per share information, in this Current Report gives effect to the reverse split of our Common Stock at a ratio of 130-to-1 effectuated on March 24, 2017 (the “Reverse Stock Split”).

 

Item 1.01

Entry Into a Material Definitive Agreement

 

As previously reported, on December 23, 2015, the Company completed an offering with six investors (the “Holders”), thereby issuing USD $3,000,000 of our two-year 11% Senior Debentures (the “Debentures”) and warrants to purchase up to 61,544 shares of Common Stock, with 50% of such shares exercisable at a price per share of $6.50 ($0.05 on a pre-Reverse Stock Split basis) and the other 50% of such shares exercisable at price per share of $9.75 ($0.075 on a pre-Reverse Stock Split basis) (all such warrants, the “Warrants”). On March 24, 2017, the Company and five of the six Holders of the Debentures, representing an aggregate principal balance of USD $2,000,000, amended the Debentures to provide that some or all of the principal balance, and accrued but unpaid interest thereon, is convertible into shares of Common Stock at the Holders’ election (such amended Debentures, the “Convertible Debentures”). The Debentures matured on December 22, 2017 (the “Original Maturity Date”).

 

Between December 22, 2017 and December 28, 2017, the Company and the Holders entered into a letter agreement dated December 21, 2017 (the “Letter Agreement”), pursuant to which the Holders agreed to extend the Original Maturity Date to April 3, 2018 (the “Extended Maturity Date”), and the Company agreed to (a) pay to the Holders an additional five percent (5%) interest payment on the principal balance of their Debentures totaling, in the aggregate, USD $150,000, of which USD $30,000 was paid and the remaining $120,000 will be paid on the Extended Maturity Date; (b) amend the Warrants to so that the exercise price of each is equal to the December 21, 2017 closing price of the Common Stock on the OTCQB Venture Marketplace (the “New Exercise Price”); and (c) issue to the Holders, pro rata based on their respective investments in the Debentures, five-year warrants to purchase, in the aggregate, up to 224,550 shares of Common Stock at the New Exercise Price (the “New Warrants”). The Convertible Debentures will continue to be convertible in accordance with the terms thereof.

 

As of December 22, 2017, Five of the six Holders and the Company entered into a Second Amendment to Senior Debenture and the remaining Holder and the Company entered into a First Amendment to Senior Debenture, all such amendments being on substantially the same terms, pursuant to which the Original Maturity Date was modified to the Extended Maturity Date (collectively, the “Debenture Amendments”). As of the same date, all Holders and the Company entered into a First Amendment to $0.05 Warrant and First Amendment to $0.075 Warrant, all such amendments being on substantially the same terms, pursuant to which the exercise price of the Warrants was modified to be equal to the New Exercise Price (collectively, the “Warrant Amendments”). Lastly, on the same date, the Company issued the New Warrants to the Holders.

 

The foregoing descriptions of the Letter Agreement, form of Debenture Amendments, form of Warrant Amendments and form of New Warrants do not purport to be complete and are qualified in their entirety by reference to the full text of the Letter Agreement, form of Debenture Amendments, form of Warrant Amendments and form of New Warrants filed as Exhibits 10.1, 10.2, 10.3 and 10.4 hereto, respectively, and are incorporated herein by reference.

 

The Company is providing this report in accordance with Rule 135c under the Securities Act of 1933, as amended (the “Securities Act”), and the notice contained herein does not constitute an offer to sell the Company’s securities, and is not a solicitation for an offer to purchase the Company’s securities. The securities offered have not been registered under the Securities Act, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

 

Item 3.02

Unregistered Sales of Equity Securities  

 

Reference is made to the disclosure set forth under Item 1.01 above, which disclosure is incorporated herein by reference.

 

The Company has sold the Securities in a private transaction in reliance on the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder since, among other things, the above transaction did not involve a public offering. Additionally, the Company relied on similar exemptions under applicable state laws. The Holders had access to information about the Company and their investments, took the securities for investment and not resale, and the Company took appropriate measures to restrict the transfer of the securities. Upon issuance, the resale of the securities will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 

Item 9.01

Financial Statements and Exhibits.

 

The following exhibits are furnished as part of this Current Report on Form 8-K/A:

 

(d) Exhibits.

 

  10.1 Letter Agreement, dated December 22, 2017, between the Company and the Holders.
  10.2 Form of Debenture Amendments, between the Company and the Holders.
  10.3 Form of Warrant Amendments, between the Company and the Holders.
  10.4 Form of New Warrants issued on December 22, 2017 by the Company to the Holders.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  Blue Sphere Corporation
     
Dated:          December 28, 2017 By: /s/ Shlomi Palas
  Name: Shlomi Palas
  Title: President and Chief Executive Officer

 

 

 

Blue Sphere Corporation 8-K/A

 

Exhibit 10.1

 

December 21, 2017

 

By Email

Tony Tortorella

Jeff Denny

Gary Haseley

Alfred Brand

Tom McDonough

Ronnie Billitier

 

Re:          Senior Debenture/Maturity Date Extension and Warrants

 

Gentlemen:

 

Reference is made to that certain Subscription Agreement, dated December 23, 2015, pursuant to which each of you purchased from Blue Sphere Corporation (“We”, the “Company” or “Blue Sphere”) a Senior Debenture, as subsequently amended (except for Mr. Gary Haseley), in the aggregate principal amount of $3,000,000 (each a “Senior Debenture” and collectively, the “Senior Debentures”), and a $0.05 Warrant (“$0.05 Warrant”) and a $0.075 Warrant (“$0.075 Warrant”, and with the $0.05 Warrant, the “Warrants”) pursuant to the terms and conditions stated therein (the “December 2015 Offering”). Capitalized terms used in this letter agreement shall have the meaning ascribed to such terms in the Senior Debenture or the Warrants, as the case may be.

 

Thank you for agreeing to extend the Maturity Date of your Senior Debenture to April 3, 2018 (the “Maturity Date Extension”). We appreciate your cooperation in this regard and, in turn, agree to the following:

 

(i)             Interest Payment under Senior Debenture: Blue Sphere shall make two (2) payments totaling an aggregate of five percent (5%) of the total principal invested by your group, or $3,000,000 (the “Group”). Accordingly, we shall pay an aggregate of $30,000 upon the execution of this letter agreement by all members of the Group, and an additional payment of $120,000 in the aggregate on April 3, 2018, the new maturity date of your Senior Debenture; such payment being in addition to re-payment of the Principal Amount. The interest payments made pursuant to this letter agreement shall be on a pro rata basis to each of you, based on your investment relative to the other members of the Group, as more fully detailed on Schedule A attached hereto.

 

(ii)            Repricing of Warrant Exercise Prices: Blue Sphere shall amend your Warrants to reflect new Exercise Prices equal to the closing price of the Company’s common stock on December 21, 2017 (“December 21st Closing Price”). Specifically, each $0.05 Warrant and $0.075 Warrant issued to you in connection with the December 2015 Offering shall be repriced in accordance with this section (ii).

 

(iii)           New Warrant : Blue Sphere shall issue new warrants to purchase up to an aggregate of 224,550 shares of the Company’s common stock, at an exercise price equal to the December 21st Closing Price (the “New Warrants”). The New Warrants shall be issued on a pro rata basis to each of you, based on your investment relative to the other members of the Group, as more fully detailed on Schedule A attached hereto.

 

 

 

 

In connection with consummating the foregoing, please find attached to this letter agreement the Second Amendment to Senior Debenture (except for Mr. Haseley who shall receive a First Amendment to the Senior Debenture), First Amendment to $0.05 Warrant, First Amendment to $0.075 Warrant and a New Warrant, attached hereto as Exhibit A, Exhibit B, Exhibit C, and Exhibit D, respectively. Each of these documents has been signed by the Company. Therefore, please countersign each where indicated and return a copy to us, along with your countersignature to this letter agreement. We shall provide to you a set of all closing documents, including original copies of the securities and payment of the interest in section (i) to you, as soon as possible, following receipt of countersigned documents from all members of the Group.

 

Once again, thank you for your continued support of Blue Sphere.

 

  Very truly yours,
     
  Blue Sphere Corporation
     
  By:   
  Name: Shlomi Palas
  Title: Chief Executive officer

  

Accepted and Agreed to as of the date first written above:

 

HOLDER: 

     
     
(entity name, if applicable)  
     
By:    
     
Name:     
     
Title:    

 

cc: Robert Leone, Esq.

cc: Peter J. Gennuso, Esq.

 

 

 

Blue Sphere Corporation 8-K/A

 

Exhibit 10.2

 

[FIRST]/[SECOND] AMENDMENT TO SENIOR DEBENTURE

 

THIS [FIRST]/[SECOND]AMENDMENT TO SENIOR DEBENTURE (this “ Amendment ”) is made as of December 22, 2017 (the “ Effective Date ”) by and between Blue Sphere Corporation, a Nevada corporation (the “ Company ”), and the undersigned (the “ Holder ”).

 

WHEREAS , the Company issued to Holder a Senior Debenture, dated December 23, 2015, numbered and in the principal amount as set forth on the signature page hereto (the “ Debenture ”), which bears interest at a rate of 11% per annum, and matures on December 22, 2017;

 

[ WHEREAS, on or about March 24, 2017, the Company and the Holder entered into that certain First Amendment to Senior Debenture, providing for the amendment to the Debenture as detailed therein;]

 

WHEREAS , the Company and the Holder desire to amend the Debenture again on the terms and subject to the conditions set forth herein; and

 

WHEREAS , pursuant to Section 11 of the Debenture, the amendment contemplated by the Company and the Holder must be contained in an instrument in writing, signed by the parties.

 

NOW, THEREFORE , in consideration of the premises contained herein and other good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:

 

1.                Definitions .  Capitalized terms used but not defined in this Amendment shall have the meaning ascribed to such terms in the Debenture.

  

2.                Maturity Date. The Maturity Date set forth in the Debenture shall be changed from “December 22, 2017” to “April 3, 2018.”

 

3.                Date of Effectiveness; Limited Effect .  This Amendment will be deemed effective as of the Effective Date. Except as expressly provided in this Amendment, all of the terms and provisions of the Debenture are and will remain in full force and effect and are hereby ratified and confirmed by the Company and the Holder. On and after the Effective Date, each reference in the Debenture to “this Debenture,” “the Debenture,” “hereunder,” “hereof,” “herein” or words of like import, and each reference to the Debenture in any other agreements, documents or instruments executed and delivered pursuant to, or in connection with, the Debenture, will mean and be a reference to the Debenture as amended by this Amendment.

 

4.                Representations and Warranties . Each party hereby represents and warrants to the other party that: (a) it has the full right, power and authority to enter into this Amendment and to perform its obligations hereunder and under the Debenture, as amended by this Amendment; (b) the execution of this Amendment by the individual whose signature is set forth at the end of this Amendment on behalf of such party, and the delivery of this Amendment by such party, have been duly authorized by all necessary action on the part of such party; and (c) this Amendment has been executed and delivered by such party and (assuming due authorization, execution and delivery by the other party hereto) constitutes the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms.

 

1

 

 

5.                Miscellaneous .  This Amendment (a) constitutes the sole and entire agreement of the parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to such subject matter; (b) may be amended only by a writing signed by each of the parties; (c) may be executed in several counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument; (d) shall be governed by, and construed and enforced in accordance with, the laws of the State of Nevada, without giving effect to any conflict of law rules; and (d) shall be binding upon, and inure to the benefit of, the parties and their respective successors and permitted assigns.

 

[remainder of page left intentionally blank]

 

2

 

 

IN WITNESS WHEREOF , the parties hereto have executed this Amendment as of the Effective Date.

 

COMPANY: 

     
BLUE SPHERE CORPORATION  
     
By:    
Name:  Shlomi Palas  
Title: Chief Executive Officer  

 

HOLDER: 

     
(entity name, if applicable)  
     
By:    
     
Name:     
     
Title:    

  

DEBENTURE:

 

Debenture Number: D-DEC-2015-___________
   
Principal Amount: USD $ ________________

 

3

 

Blue Sphere Corporation 8-K/A

 

Exhibit 10.3

 

FIRST AMENDMENT TO [$0.05]/[$0.075] WARRANT

 

THIS FIRST AMENDMENT TO [$0.05]/[$0.075] WARRANT (this “ Amendment ”) is made as of December 22, 2017 (the “ Effective Date ”) by and between Blue Sphere Corporation, a Nevada corporation (the “ Company ”), and the undersigned (the “ Holder ”).

 

WHEREAS , the Company issued to Holder a Warrant, dated December 23, 2015, numbered and providing for the Holder to purchase Warrant Shares as more fully detailed therein (the “ Warrant ”);

 

WHEREAS , the Company and the Holder desire to amend the Warrant on the terms and subject to the conditions set forth herein; and

 

WHEREAS , pursuant to Section 11(a) of the Warrant, the amendment contemplated by the Company and the Holder must be contained in an instrument in writing, signed by the parties.

 

NOW, THEREFORE , in consideration of the premises contained herein and other good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:

 

1.           Definitions . Capitalized terms used but not defined in this Amendment shall have the meaning ascribed to such terms in the Warrant.

 

2.           Exercise Price. The Exercise Price of the Warrant shall be changed from “$[0.05]/[0.075] per share” to “$1.60 per share”.

 

3.           Date of Effectiveness; Limited Effect . This Amendment will be deemed effective as of the Effective Date. Except as expressly provided in this Amendment, all of the terms and provisions of the Warrant are and will remain in full force and effect and are hereby ratified and confirmed by the Company and the Holder. On and after the Effective Date, each reference in the Warrant to “this Warrant” “the Warrant,” “hereunder,” “hereof,” “herein” or words of like import, and each reference to the Warrant in any other agreements, documents or instruments executed and delivered pursuant to, or in connection with, the Warrant, will mean and be a reference to the Warrant as amended by this Amendment.

 

4.           Representations and Warranties . Each party hereby represents and warrants to the other party that: (a) it has the full right, power and authority to enter into this Amendment and to perform its obligations hereunder and under the Warrant, as amended by this Amendment; (b) the execution of this Amendment by the individual whose signature is set forth at the end of this Amendment on behalf of such party, and the delivery of this Amendment by such party, have been duly authorized by all necessary action on the part of such party; and (c) this Amendment has been executed and delivered by such party and (assuming due authorization, execution and delivery by the other party hereto) constitutes the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms.

 

5.           Miscellaneous . This Amendment (a) constitutes the sole and entire agreement of the parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to such subject matter; (b) may be amended only by a writing signed by each of the parties; (c) may be executed in several counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument; (d) shall be governed by, and construed and enforced in accordance with, the laws of the State of Nevada, without giving effect to any conflict of law rules; and (d) shall be binding upon, and inure to the benefit of, the parties and their respective successors and permitted assigns.

 

1

 

 

IN WITNESS WHEREOF , the parties hereto have executed this Amendment as of the Effective Date.

 

COMPANY:

 

BLUE SPHERE CORPORATION

     
By:    
Name: Shlomi Palas  
Title: Chief Executive Officer  

 

HOLDER:

   
(entity name, if applicable)  

 

By:    
     
Name:  
     
Title:    

  

WARRANT:

 

Warrant Number: W-DEC-2015-___________  

 

2

 

Blue Sphere Corporation 8-K/A

 

Exhibit 10.4

 

BLUE SPHERE CORPORATION

 

WARRANT

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON ITS EXERCISE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ ACT’ ), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY ONLY BE ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THIS WARRANT AND THE SECURITIES ISSUABLE UPON ITS EXERCISE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT OR SUCH SECURITIES UNDER THE ACT AND QUALIFICATION UNDER APPLICABLE STATE LAW WITHOUT AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED UNDER THE ACT OR RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION (THE “ SEC ”).

 

WARRANT NUMBER:

W-DEC-2017-___

ISSUANCE DATE:

December 22, 2017

 

FOR VALUE RECEIVED , BLUE SPHERE CORPORATION, as of December 22, 2017 (the “ Issuance Date ”) a Nevada corporation (the “ Company ”), hereby certifies that ________________, or its registered assigns (the “ Warrant Holder ”), is entitled, subject to the terms set forth below, to purchase from the Company [___] shares (the “ Warrant Shares ”) of the Company’s common stock, $0.001 par value per share (the “ Common Stock ”), exercisable at price per share of $1.60 per share (the “ Exercise Price ”). This Warrant may be exercised any time after issuance through and including the fifth (5th) anniversary of the Issuance Date (the “ Expiration Date ”), subject to the following terms and conditions set out in this Warrant.

 

1.             Registration of Warrant . The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “ Warrant Register ”), in the name of the record Warrant Holder hereof from time to time. The Company may deem and treat the registered Warrant Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Warrant Holder, and for all other purposes, and the Company shall not be affected by notice to the contrary.

 

2.             Investment Representation . The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or the account of an affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities laws. The Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that they have not been registered under the Act and may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration requirements of the Act and in accordance with federal and state securities laws. If this Warrant was acquired by the Warrant Holder pursuant to the exemption from the registration requirements of the Act afforded by Regulation S thereunder, the Warrant Holder acknowledges and covenants that this Warrant may not be exercised by or on behalf of a Person during the one year distribution compliance period (as defined in Regulation S) following the date hereof. “ Person ” means an individual, partnership, firm, limited liability company, trust, joint venture, association, corporation, or any other legal entity.

 

1

 

 

3.             Validity of Warrant and Issue of Shares . The Company represents and warrants that this Warrant has been duly authorized and validly issued and warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof. The Company further warrants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of Common Stock to provide for the exercise of the rights represented by this Warrant.

 

4.             Registration of Transfers and Exchange of Warrants .

 

(a)          Subject to compliance with the legend set forth on the face of this Warrant, the Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to the Company at the office specified in or pursuant to Section 10. Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of this Warrant (any such new warrant, a “ New Warrant ”), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder of a Warrant.

 

(b)          This Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 10 for one or more New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder. Any such New Warrant will be dated the date of such exchange.

 

5.             Exercise of Warrants .

 

(a)          This Warrant shall be exercisable at any time and from time to time from and after the Issuance Date and through and including the Expiration Date, for such number of Warrant Shares as is indicated in the form of Election to Purchase, which is attached hereto and incorporated herein as Exhibit A . If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares for which no exercise has been evidenced by this Warrant. At 5:00 P.M., New York time on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value.

 

(b)         Exercise of this Warrant shall be made upon surrender of this Warrant with an Election to Purchase in the form attached hereto (or attached to such New Warrant), duly completed and signed to the Company, at its address set forth in Section 10.

 

(c)          A “ Date of Exercise ” means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable), with an Election to Purchase in the form attached hereto (or attached to such New Warrant), appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased, as set forth herein.

 

2

 

 

(d)          Payment upon exercise may be made at the written option of the Warrant Holder either by cashless exercise, as set forth in Section 6, or in cash, wire transfer or by certified or official bank check payable to the order of the Company equal to the applicable aggregate purchase price, for the number of Warrant Shares specified in the Election to Purchase (as such exercise number shall be adjusted to reflect any adjustment in the total number of Warrant Shares issuable to the Warrant Holder per the terms of this Warrant) and the Warrant Holder shall thereupon be entitled to receive the number of duly authorized, validly issued, fully-paid and non-assessable Warrant Shares determined as provided herein.

 

(e)          The Company shall promptly, but in no event later than ten (10) business days after the Date of Exercise as defined herein, issue or cause to be issued and cause to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate (subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a certificate for the Warrant Shares issuable upon such exercise, with such restrictive legend as required by the Act, as applicable. Any person so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the Date of Exercise of this Warrant.

 

6.             Cashless Exercise .

 

(a)          If at any time prior to the Expiration Date there is not an effective registration statement on file with the SEC covering the resale of the Warrant Shares by the Warrant Holder, then at such time this Warrant may also be exercised by means of a cashless exercise. In such event, the Holder shall surrender this Warrant to the Company, together with a notice of cashless exercise, and the Company shall issue to the Holder the number of Warrant Shares determined as follows:

 

X = Y (A-B)/A

 

where:

 

  X = The number of Warrant Shares to be issued to the Holder.
  Y = The number of Warrant Shares with respect to which this Warrant is being exercised.
  A = The average closing bid price of the Common Stock for the five (5) trading days immediately prior to the Date of Exercise.
  B = The Exercise Price.

 

(b)          For purposes of Rule 144 of the Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Warrant Holder, and the holding period for the Warrant Shares shall be deemed to have been commenced, on the issue date. Notwithstanding anything in this Warrant to the contrary, the Warrant Holder is limited in the amount of this Warrant it may exercise.

 

3

 

 

7.             Fractional Shares . The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. The number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate number of Warrants Shares purchasable on exercise of this Warrant so presented. If any fraction of a Warrant Share would, except for the provisions of this Section 7, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up to the next whole number.

 

8.             Exercise Price Adjustments . The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 8. If, at any time while this Warrant is outstanding, the Company shall issue or cause to be issued rights or warrants to acquire or otherwise sell or distribute shares of Common Stock for a consideration per share less than the Exercise Price then, forthwith upon such issue or sale, the Exercise Price shall be reduced to the price (calculated to the nearest one hundredth of a cent) determined by multiplying the Exercise Price in effect immediately prior thereto by a fraction, the numerator of which shall be the sum of (i) the number of shares of Common Stock outstanding immediately prior to such issuance, and (ii) the number of shares of Common Stock which the aggregate consideration received (or to be received, assuming exercise or conversion in full of such rights, warrants and convertible securities) for the issuance of such additional shares of Common Stock would purchase at such Exercise Price, and the denominator of which shall be the sum of the number of shares of Common Stock outstanding immediately after the issuance of such additional shares.

 

9.             No Registration; Compliance with Reporting Requirements . The Company shall take all actions, including timely filing all reports and other documents with the SEC, necessary for the Warrant Holder to, and will refrain from taking any actions which would prevent the Warrant Holder from being able to, sell or transfer the Warrant Shares (a) obtained by means of a cashless exercise pursuant to Section 9 within six (6) months following the Issuance Date or (b) otherwise obtained by exercise of this Warrant within six (6) months following the Date of Exercise.

 

10.           Notice . All notices, requests, demands, claims and other communications hereunder shall be in writing and shall be delivered by certified or registered mail (first class postage pre-paid), guaranteed overnight delivery, or facsimile transmission if such transmission is confirmed by delivery by certified or registered mail (first class postage pre-paid) or guaranteed overnight delivery, to the following addresses (or to such other addresses which such party shall subsequently designate in writing to the other party):

 

(a)           If to the Company:

Blue Sphere Corporation

301 McCullough Drive, 4th Floor

Charlotte, North Carolina 28262

Attention: Shlomi Palas

 

with a copy to:

Thompson Hine LLP

335 Madison Avenue, 12th Floor

New York, NY 10017

Attention: Peter J. Gennuso, Esq.

 

4

 

 

(b)          If to the Warrant Holder, to the address set forth for notice in the Subscription Agreement, dated as of the date hereof, between the Warrant Holder and the Company.

 

11.           Miscellaneous .

 

(a)          This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Warrant may be amended only in writing and signed by the Company and the Warrant Holder.

 

(b)          Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant Holder.

 

(c)          This Warrant shall not be transferable by the Warrant Holder and shall be exercisable only by the Warrant Holder. Without the prior written consent of the Company, the Warrant shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Warrant or of any rights granted hereunder contrary to the provisions of this section, or the levy of any attachment or similar process upon the Warrant or such rights, shall be null and void.

 

(d)         The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.

 

(e)          In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

(f)          The Warrant Holder shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant.

 

(g)         This Warrant shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws.

 

(h)         The Company and the Warrant Holder shall submit all disputes arising under this Warrant to arbitration in New York, New York before a single arbitrator of the American Arbitration Association (the “ AAA ”). The arbitrator shall be selected by application of the rules of the AAA, or by mutual agreement of the parties, except that such arbitrator shall be an attorney admitted to practice law in the State of New York. No party hereto will challenge the jurisdiction or venue provisions as provided in this section. Nothing in this section shall limit the Warrant Holder’s right to obtain an injunction for a breach of this Agreement from a court of law. Any injunction obtained shall remain in full force and effect until the arbitrator fully adjudicates the dispute.

 

[Signature Page Follows]

 

5

 

 

IN WITNESS WHEREOF, the Company and Holder have caused this Warrant to be duly executed by the authorized officer as of the date first above stated.

       
  THE COMPANY:  
       
  blue sphere corporation  
       
  By:    
  Name: Shlomi Palas  
  Title: Chief Executive Officer  
       
       
  WARRANT HOLDER:  
     
     
 

(entity name, if applicable}

 
       
       
  By:    
       
  Name:    
       
  Title:    

 

[Signature Page to Warrant]

 

 

 

FORM OF ELECTION TO PURCHASE  

(To be executed by the Warrant Holder to exercise the right to  

purchase shares of Common Stock under the foregoing Warrant) 

 

Blue Sphere Corporation 

 

Re: Election to Purchase Shares of Common Stock Under the Warrant

 

Gentlemen: 

 

In accordance with the Warrant enclosed with this Election to Purchase, the undersigned hereby irrevocably elects to purchase _____________ shares of Common Stock of Blue Sphere Corporation at an Exercise Price of $____, and encloses herewith $____________ in cash, certified or official bank check(s), which sum represents the aggregate price for the number of shares of Common Stock to which this Election to Purchase relates, together with any applicable taxes payable by the undersigned pursuant to the Warrant. Any capitalized terms used but not defined in this Election to Purchase shall have the meaning ascribed to them in the accompanying Warrant.

 

The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the name of: 

 

  Name:  
     
  Taxpayer ID:  
     
  Address:  
     
     

 

If the number of shares of Common Stock issuable upon this exercise shall not be all of the shares of Common Stock which the undersigned is entitled to purchase in accordance with the enclosed Warrant, the undersigned requests that a New Warrant evidencing the right to purchase the shares of Common Stock not issuable pursuant to the exercise evidenced hereby be issued in the name of and delivered to:

 

  Name:  
     
  Address:  
     
     

 

The undersigned represents and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities Act”), or pursuant to an exemption from registration under the Securities Act.

 

HOLDER:

 

Name:    
     
By:    
     
Title:    
     
Dated: __________________, _________  

  

(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)